Ranbaxy gets USFDA nod for diabetic drug

Drug maker Ranbaxy’s wholly-owned US subsidiary receives USFDA approval to market Metformin Hydrochloride tablets.

Orchid gets USFDA nod for non-antibiotic drug

Daiichi gets SEBI, FIPB nod for stake acquisition in Ranbaxy

This entry was posted on Thursday, August 14th, 2008 at 2:31 pm and is filed under Indian Stock Market News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Indian Stock Market

Ranbaxy gets USFDA nod for diabetic drug

Leave a Reply

Categories

Archives

Feed

Links

Subscribe by E-Mail :

Recent Posts

Recent Comments

Indian Stock Market News